Munich, Germany

Kristina Schoedel

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Medigene Immunotherapies Gmbh. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kristina Schoedel. Retrieved from https://idiyas.com/inventor/kristina-schoedel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Kristina Schoedel

Introduction

Kristina Schoedel is a prominent inventor based in Munich, Germany. She has made significant strides in the field of immunotherapy, particularly through her innovative work on T cell receptors. Her contributions are vital in advancing therapeutic options for various diseases.

Latest Patents

Kristina Schoedel holds a patent for "Inducible T cell receptors and uses thereof." This patent involves combinations comprising one or more nucleic acid molecules that encode for TCR alpha and beta chains linked to dimerization domains. The patent also covers proteins encoded by these nucleic acid molecules and their corresponding uses and methods. She has 1 patent to her name.

Career Highlights

Kristina is currently associated with Medigene Immunotherapies GmbH, where she continues to push the boundaries of immunotherapy research. Her work is instrumental in developing new treatments that harness the power of the immune system.

Collaborations

Throughout her career, Kristina has collaborated with notable colleagues, including Slavoljub Milosevic and Adriana Turqueti Neves. These partnerships have enriched her research and contributed to the success of her projects.

Conclusion

Kristina Schoedel's innovative work in the field of immunotherapy exemplifies the impact of dedicated research and collaboration. Her contributions are paving the way for future advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…